Yu Haiyang, Chakravorty Samya, Song Weihua, Ferenczi Michael A
Lee Kong Chian School of Medicine, Nanyang Technological University, Experimental Medicine Building, Level 3, 59 Nanyang Drive, Singapore, 636921, Singapore.
Eur Biophys J. 2016 Dec;45(8):779-805. doi: 10.1007/s00249-016-1128-z. Epub 2016 Apr 15.
Phosphorylation of the regulatory light chain (RLC) of myosin modulates cellular functions such as muscle contraction, mitosis, and cytokinesis. Phosphorylation defects are implicated in a number of diseases. Here we focus on striated muscle where changes in RLC phosphorylation relate to diseases such as hypertrophic cardiomyopathy and muscular dystrophy, or age-related changes. RLC phosphorylation in smooth muscle and non-muscle cells are covered briefly where relevant. There is much scientific interest in controlling the phosphorylation levels of RLC in vivo and in vitro in order to understand its physiological function in striated muscles. A summary of available and emerging in vivo and in vitro methods is presented. The physiological role of RLC phosphorylation and novel pathways are discussed to highlight the differences between muscle types and to gain insights into disease processes.
肌球蛋白调节性轻链(RLC)的磷酸化可调节细胞功能,如肌肉收缩、有丝分裂和胞质分裂。磷酸化缺陷与多种疾病有关。在这里,我们重点关注横纹肌,其中RLC磷酸化的变化与肥厚性心肌病和肌肉萎缩症等疾病或与年龄相关的变化有关。在相关情况下,将简要介绍平滑肌和非肌肉细胞中的RLC磷酸化。为了了解其在横纹肌中的生理功能,人们对体内和体外控制RLC磷酸化水平有着浓厚的科学兴趣。本文总结了现有的和新出现的体内和体外方法。讨论了RLC磷酸化的生理作用和新途径,以突出肌肉类型之间的差异,并深入了解疾病过程。